HepaLife™ Technologies, Inc. (HPLF.OB) Announces the Presentation of Bioartificial Liver Device Data at the International Stem Cell Conference
HepaLife™ announced that the company will present new data from ongoing research and development of the artificial liver device technology at the 6th Annual Meeting of the International Society for Stem Cell Research on June 11-14, 2008 at the Pennsylvania Convention Center in Philadelphia, Pennsylvania. Earlier this month HepaLife™ also announced that the company’s proprietary bioartificial liver device successfully demonstrated key liver functions in a model of the human liver failure environment, which now prompts researchers to move toward in vivo animal studies. The ISSCR Annual Meeting brings an elite audience of biotechnology visionaries, researchers and governmental representatives to talk…